SGP
SpyGlass Pharma, Inc.
23.90$
-3.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +14.9% | +8.1% | +2.4% | +57.9% | +46.7% | +7.2% | – | |
| – | -15.4% | +70.1% | +58.7% | -1.0% | +81.6% | +24.5% | – | |
| – | -325.4% | – | -110.8% | – | -168.4% | – | – | |
| – | -62.6% | -68.3% | +193.3% | +175.7% | +60.8% | +185.8% | – | |
| – | – | – | – | – | -390.1% | -44.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | +35,038.8% | +50.9% | -100.3% | +279.6% | – | -100.0% | – | |
| – | – | +65.9% | -130.7% | – | – | -111.1% | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.